Manufacturer of Controlled Substances; Notice of Registration, 68196 [E7-23511]
Download as PDF
<![CDATA[
68196
Federal Register / Vol. 72, No. 232 / Tuesday, December 4, 2007 / Notices
Drug
Schedule
Methamphetamine (1105) ............
Phenylacetone (8501) ..................
Raw Opium (9600) .......................
Poppy Straw Concentrate (9670)
II
II
II
II
The company plans to import the
listed controlled substances to
manufacture bulk controlled substances
for sale to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Chattem Chemicals, Inc. to import the
basic classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated Chattem
Chemicals, Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with State and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Dated: November 26, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–23512 Filed 12–3–07; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
mstockstill on PROD1PC66 with NOTICES
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated August 16, 2007, and
published in the Federal Register on
August 27, 2007, (72 FR 49020), Chemic
Laboratories, Inc., 480 Neponset Street,
Building 7, Canton, Massachusetts
02021, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of Cocaine (9041), a basic
class of controlled substance listed in
schedule II.
The company plans to manufacture
small quantities of the above listed
controlled substance for distribution to
its customers for the purpose of
research.
VerDate Aug<31>2005
17:38 Dec 03, 2007
Jkt 214001
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Chemic Laboratories, Inc. to
manufacture the listed basic class of
controlled substance is consistent with
the public interest at this time. DEA has
investigated Chemic Laboratories, Inc.
to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with State
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic class of controlled substance
listed.
Dated: November 26, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–23511 Filed 12–3–07; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Ammar Sabbagh; Denial of Application
On June 12, 2006, the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, issued an Order to
Show Cause to Ammar Sabbagh
(Respondent), of Sheridan, Oregon. The
Show Cause Order proposed the denial
of Respondent’s pending application for
a DEA Certificate of Registration as a
distributor of the list I chemicals
ephedrine and pseudoephedrine, on the
ground that his ‘‘registration would be
inconsistent with the public interest.’’
Show Cause Order at 1 (quoting 21
U.S.C. 823(h)).
More specifically, the Show Cause
Order alleged that on November 4, 2005,
Respondent pled guilty to conspiring to
distribute pseudoephedrine, in violation
of 21 U.S.C. 841(c)(2)–(3), and 846. Id.
at 2. The Show Cause Order thus alleged
that Respondent’s proposed sales of list
I chemical products would be
inconsistent with the public interest. Id.
The Show Cause Order further informed
Respondent of his right to request a
hearing on the allegations. Id.
On June 19, 2006, the Show Cause
Order was served on Respondent by
certified mail addressed to him at his
new residence at the Federal
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
Correctional Institution in Sheridan,
Oregon. Since that time, neither
Respondent, nor anyone purporting to
represent him, has responded. Because
(1) more than thirty days have passed
since service of the Show Cause Order,
and (2) Respondent did not timely
request a hearing, I conclude that
Respondent has waived his right to a
hearing. See 21 CFR 1301.43(d). I
therefore enter this Final Order without
a hearing based on relevant material
contained in the investigative file and
make the following findings.
Findings
On December 10, 1999, Respondent
applied for a DEA Certificate of
Registration to distribute the list I
chemicals ephedrine and
pseudoephedrine. See 21 U.S.C.
802(34). While both chemicals have
therapeutic uses, they are easily
extracted from non-prescription drug
products and used in the illicit
manufacture of methamphetamine, a
schedule II controlled substance. See 21
CFR 1308.12(d).
Methamphetamine is a powerful and
addictive central nervous system
stimulant. See Gregg Brothers Wholesale
Co., Inc., 71 FR 59830 (2006). As noted
in numerous agency orders, the illegal
manufacture and abuse of
methamphetamine pose a grave threat to
this country. Methamphetamine abuse
has destroyed numerous lives and
families and ravaged communities.
Moreover, because of the toxic nature of
the chemicals used to make
methamphetamine, its manufacture
causes serious environmental harms.
See, e.g., Id.
During the course of investigating
Respondent’s application, DEA became
aware that he was selling large
quantities of pseudoephedrine to an
individual he knew was using
methamphetamine. Thereafter,
Respondent also began supplying
pseudoephedrine to several
methamphetamine traffickers.
Respondent also met with a confidential
source and agreed to supply him with
twenty to twenty-five cases a month of
pseudoephedrine.
On March 2, 2005, a federal grand
jury returned an indictment which
charged Respondent with conspiring to
distribute pseudoephedrine, having
knowledge and reasonable cause to
believe that it would be used to
manufacture methamphetamine. First
Superseding Indictment, United States
v. Sabbagh, et. al., No. CR04–398L,
(W.D.Wash.) (citing 21 U.S.C. 841(c) &
(e); Id. 846). On March 10, 2005,
Respondent pled guilty to the charge,
and on November 4, 2005, the United
E:\FR\FM\04DEN1.SGM
04DEN1
]]>Agencies
[Federal Register Volume 72, Number 232 (Tuesday, December 4, 2007)]
[Notices]
[Page 68196]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-23511]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated August 16, 2007, and published in the Federal
Register on August 27, 2007, (72 FR 49020), Chemic Laboratories, Inc.,
480 Neponset Street, Building 7, Canton, Massachusetts 02021, made
application by renewal to the Drug Enforcement Administration (DEA) to
be registered as a bulk manufacturer of Cocaine (9041), a basic class
of controlled substance listed in schedule II.
The company plans to manufacture small quantities of the above
listed controlled substance for distribution to its customers for the
purpose of research.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Chemic Laboratories, Inc. to manufacture the listed basic class of
controlled substance is consistent with the public interest at this
time. DEA has investigated Chemic Laboratories, Inc. to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with State and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with
21 CFR 1301.33, the above named company is granted registration as a
bulk manufacturer of the basic class of controlled substance listed.
Dated: November 26, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E7-23511 Filed 12-3-07; 8:45 am]
BILLING CODE 4410-09-P
